BAYER PHARMA AKTIENGELLSCHAFT has a total of 45 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Argentina, African Regional Industrial Property Organization and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are AVANIR PHARMACEUTICALS, BAYER SHERING PHARMA AG and NOVARTIS INT PHARM LTD.
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Medical technology | |
#5 | Foods and drinks | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Philip Dr Lienau | 9 |
#2 | Gerhard Dr Siemeister | 8 |
#3 | Dirk Dr Kosemund | 6 |
#4 | Volker Dr Schulze | 5 |
#5 | Ulf Dr Bmer | 4 |
#6 | Simon Dr Holton | 4 |
#7 | Hans Dr Briem | 4 |
#8 | Knut Dr Eis | 4 |
#9 | Antje Margret Dra Wengner | 4 |
#10 | Detlef Dr Stckigt | 4 |
Publication | Filing date | Title |
---|---|---|
AP2014007731A0 | Substituted triazolopyridines and their use as ttk inhibitors | |
BRPI0308376B1 | Human anti-ED-B antibody molecule, its use and composition |